Therefore, our findings supported the hypothesis that circFARSA might contribute to the development of lung cancer by sponging miR‐330‐5p/miR‐326 and relieving their inhibitory effects on oncogene FASN. The gene discussed is FASN; the disease is lung carcinoma.